BMRA

Biomerica, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$1.3

Price (1 Year)

$2.73 $1.3

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %5.3 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.1 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels.

Website

Analysis (Turkish): BMRA Hissesi Caiz mi, Helal mi? Biomerica, Inc. Katılım Analizi